Sector: Pharmaceuticals & Biotechnology

Mid Cap

Alivus Life Sciences Share Price

Alivus Life Sciences Ltd.

₹901.15

-9.80(-1.08%)

Invest in ALIVUS with up to 2.50x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : ALIVUS

Open Free Demat Account

Alivus Life Sciences Performance

Price Movement

₹901.15

₹897.10

₹925.00

↘ Today's Low↗ Today's High

1 Year Performance

₹901.15

₹819.00

₹1225.10

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹925.00

Low₹897.10

Open at₹913.85

Prev Close₹910.95

Volumes51.23 K

Avg Price₹904.80

Lower Circuit₹728.80

Upper Circuit₹1,093.10

Historical Performance

3M High₹980.00

3M Low₹819.00

1 Yr High₹1,225.10

1 Yr Low₹819.00

3 Yr High₹1,335.10

3 Yr Low₹370.00

5 Yr High₹1,335.10

5 Yr Low₹370.00

Alivus Life Sciences Fundamentals

Market Cap

High in industry

11,087.40 Cr.

PE Ratio (TTM)

Below industry Median

20.40

Dividend Yield

Above industry Median

0.60

Net Profit TTM

23.1% incr over last year

543.69

Net Profit Growth

23.1% incr over last year

543.69

PEG Ratio

Above industry Median

0.90

ROE

15% decr over last year

17.23

Operating Revenue TTM

2,512.26

Operating Revenue Growth

10.5% incr over last year

Book Value

Above industry Median

3.70

MFI

MFI is mid-range

32.98

RSI

RSI is mid-range

47.35

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

3.70

Alivus Life Sciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	672.89	587.98	601.85	649.54	641.84
Operating Expense	441.62	408.81	429.54	451.11	451.54
Operating Profit	231.27	179.17	172.31	198.43	190.31
Depreciation	19.66	18.44	17.06	15.97	15.16
Interest	1.49	1.32	1.25	1.26	0.46
Tax	48.13	44.11	41.45	49.42	48.19
Net Profit	150.26	130.03	121.54	141.87	136.96

ALIVUS Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹882 - ₹899

Target Price

₹1,077

Stop Loss

Target Date

26 Jan 27

Potential Returns

22.11 %

View Call ↗

Alivus Life Sciences Technicals

Alivus Life Sciences Ltd. EMA & SMA

₹901.15

-9.80 (-1.08%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹904.7

Day EMA10 ₹909.7

Day EMA12 ₹910.9

Day EMA20 ₹912.3

Day EMA26 ₹911.8

Day EMA50 ₹910.3

Day EMA100 ₹919.5

Day EMA200 ₹943.4

Alivus Life Sciences Support and Resistance

Resistance

First Resistance₹919.87

Second Resistance₹936.38

Third Resistance₹947.77

Support

First Support₹891.97

Second Support₹880.58

Third Support₹864.07

Technical Indicators

Day RSI47.35

Day MFI32.98

Day ADX13.67

Day Commodity Channel Index-70.60

William-72.73

Day MACD-0.84

Day MACD Signal Line3.28

Day ATR30.94

Day ROC125-6.84

Day ROC212.25

Alivus Life Sciences Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	75	75	75	74.9	74.9	74.9
FII	7.8	6.7	6.6	6.4	6.8	5.1
DII	4.2	4.9	5.2	5.6	5.5	7.1
Public	13	13.4	13.2	13	12.8	12.9

Alivus Life Sciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	34.72 K	63.87 K	54.36%
Week	34.77 K	61.99 K	56.09%
1 Month	37.56 K	84.35 K	44.53%
6 Month	71.07 K	1.39 L	51.13%

Alivus Life Sciences SWOT Analysis

Strengths13

Weakness8

Opportunity6

Threats3

Companies with no Debt

Benjamin Graham Value Screen

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stocks Outperforming their Industry Price Change in the Quarter

Alivus Life Sciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
01 Sep, 2025	5	FINAL	01 Sep, 2025	Equity Share
17 Oct, 2023	22.5	INTERIM	17 Oct, 2023	Equity Share
24 Mar, 2023	21	INTERIM	24 Mar, 2023	Equity Share
15 Sep, 2022	10.5	FINAL		Equity Share
22 Nov, 2021	10.5	INTERIM	23 Nov, 2021	Equity Share

Alivus Life Sciences Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.
Price (₹)	₹1,577	₹628.95	₹780	₹968	₹1,320	₹4,075
% Change	3.47%	-5.40%	-0.01%	2.83%	3.96%	0.75%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹2,169.86	₹1,419.33	₹798.10
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹332.94	₹20.10	₹217.90
PE TTM	-	-	62.20	61.50	754.90	43.10
1 Year Return	48.29	6.51	60.63	37.17	3.9	-12.48
ROCE	30.24	34.78	34.76	12.51	3.26	-

Similar Stocks

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 474.00

-0.91%

BLUEJET

Blue Jet Healthcare Ltd

₹ 391.40

+9.99%

CONCORDBIO

Concord Biotech Ltd.

₹ 1103.00

+0.46%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 687.60

-1.60%

SUPRIYA

Supriya Lifescience Ltd.

₹ 670.00

-1.17%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2138.50

+1.52%

COHANCE

Cohance Lifesciences Ltd.

₹ 315.10

+3.18%

ERIS

Eris Lifesciences Ltd.

₹ 1358.00

+1.16%

SYNGENE

Syngene International Ltd.

₹ 448.60

+1.33%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 774.90

+1.55%

STAR

Strides Pharma Science Ltd.

₹ 872.90

+0.37%

GRANULES

Granules India Ltd.

₹ 598.00

-0.18%

FDC

FDC Ltd.

₹ 383.00

+3.82%

SHILPAMED

Shilpa Medicare Ltd.

₹ 329.00

+1.29%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 900.00

+3.15%

NATCOPHARM

Natco Pharma Ltd.

₹ 886.00

-0.64%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1739.00

+2.77%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 13507.00

+6.88%

MARKSANS

Marksans Pharma Ltd.

₹ 179.32

+0.53%

SANOFI

Sanofi India Ltd.

₹ 4080.00

+1.34%

PGHL

Procter & Gamble Health Ltd.

₹ 5080.00

+1.21%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 674.90

-2.16%

FAQ's on ALIVUS

What is the current share price of Alivus Life Sciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Alivus Life Sciences Ltd. is ₹ 901.15 on the NSE and ₹ 902.25 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Alivus Life Sciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Alivus Life Sciences Ltd. is approximately ₹ 11087.4 Cr.

What are the PE and PB ratios for Alivus Life Sciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Alivus Life Sciences Ltd. is 20.4, and the Price-to-Book (PB) ratio is 3.7.

What is the 52-Week High and Low for Alivus Life Sciences Ltd.?

Over the past 52 weeks, the highest price reached by Alivus Life Sciences Ltd. shares was ₹ 1225.1, and the lowest price was ₹ 819.

What is the current dividend yield for Alivus Life Sciences Ltd.?

As of 6 June 2025, the dividend yield for Alivus Life Sciences Ltd. is 0.6%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Alivus Life Sciences Ltd.?

Significant shareholdings in Alivus Life Sciences Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Alivus Life Sciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Alivus Life Sciences Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Alivus Life Sciences Ltd.?

Alivus Life Sciences Ltd. last declared a FINAL dividend of ₹ 5 per share for the financial period ending 2025. The record date was set as 2025-09-01, and the payment was/is scheduled around 2025-09-01. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy